Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015.

Format:

Book

Government document

Author/Creator:

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security, author.

Series:

United States. Congress. Senate. S. hrg. ; 114-700.

S. hrg. ; 114-700

Language:

English

Subjects (All):

United States. Food and Drug Administration--Rules and practice.

United States.

United States. Food and Drug Administration.

Pharmaceutical biotechnology--United States--Management.

Pharmaceutical biotechnology.

Pharmaceutical biotechnology--Government policy--United States.

Drug development--Government policy--United States.

Drug development.

Drugs--Generic substitution--Government policy--United States.

Drugs.

Genre:

Online resources.

Legislative hearings

Rules

Legislative hearings.

Physical Description:

1 online resource (iii, 40 pages) : illustrations.

Place of Publication:

Washington : U.S. Government Publishing Office, 2017.

Notes:

Online resource, PDF version; title from title page (FDsys web site, viewed on Nov. 7, 2017).

Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.

Includes bibliographical references.

Other Format:

Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. Biosimilar implementation

Microfiche version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. Biosimilar implementation

OCLC:

1010499051